To investigate whether the effect of RUNX2 could be extended to a broader scope of cancers, we performed tissue microarray using immunohistochemical staining to analyze the expression of RUNX2 in 6 patients with other carcinomas (i.e., thyroid, rectum, liver, and lung)”. Here, RUNX2 is linked to carcinoma.